Holen Sie sich die Stockscreener-App
2.44
0.62%
0.015
Handel nachbörslich:
2.48
0.04
+1.64%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BMRA?
Forum
Prognose
Aktiensplit
Biomerica Inc Aktie (BMRA) Neueste Nachrichten
Trend Recap: Is Biomerica Inc being accumulated by smart moneyQuarterly Profit Summary & Smart Swing Trading Alerts - baoquankhu1.vn
Short Covering: What is the next catalyst for Biomerica IncDip Buying & Daily Volume Surge Trade Alerts - baoquankhu1.vn
Should value investors consider Biomerica Inc2025 Trading Volume Trends & Free Verified High Yield Trade Plans - baoquankhu1.vn
Short Covering: Is Biomerica Inc stock risky to hold nowWeekly Stock Analysis & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Macro Review: Is Biomerica Inc backed by strong institutional buying2025 Breakouts & Breakdowns & Technical Pattern Alert System - baoquankhu1.vn
US-based Biomerica reports net sales of USD 1.21M in Q2 2026 - Medical Buyer
Medical diagnostics firm Biomerica's Q2 revenue falls amid product transition - TradingView — Track All Markets
BIOMERICA INC SEC 10-Q Report - TradingView
Medicare sets $300 price for IBS test as Biomerica expands AI diet tool - Stock Titan
Short Interest in Biomerica, Inc. (NASDAQ:BMRA) Expands By 123.2% - Defense World
Bullfrog AI Holdings, Inc. (NASDAQ:BFRGW) Short Interest Update - Defense World
Earnings Miss: Is Biomerica Inc stock risky to hold nowPortfolio Update Summary & AI Based Trade Execution Alerts - baoquankhu1.vn
How interest rate cuts could boost Biomerica Inc. stockPortfolio Value Summary & Free Verified High Yield Trade Plans - Улправда
Will Biomerica Inc. stock maintain dividend yield2025 Key Highlights & Expert Approved Momentum Ideas - Улправда
Is Biomerica Inc. stock safe for conservative investorsBuy Signal & Reliable Breakout Forecasts - Улправда
Can Captivision Inc. stock deliver strong Q4 earningsTreasury Yields & Daily Entry Point Trade Alerts - Улправда
How Biomerica Inc. stock responds to policy changesInsider Selling & Weekly Setup with ROI Potential - Улправда
How supply chain issues affect Rain Enhancement Technologies Holdco Inc. Equity Warrant stockQuarterly Portfolio Report & Risk Adjusted Swing Trade Ideas - Улправда
Why CRVS stock is rated strong buyWeekly Gains Summary & Fast Moving Market Watchlists - Улправда
Will Bulten AB (publ) (3FB) stock return to pre crash levels2025 Dividend Review & Technical Entry and Exit Tips - Улправда
Targets Report: Why Adams Natural Resources Fund Inc. stock remains stableWeekly Investment Recap & Risk Controlled Stock Alerts - Улправда
Is The Vita Coco Company Inc. stock trading at a premium valuationIPO Watch & Safe Capital Growth Plans - Улправда
Zodiac Energy Limited (ZODIAC) Signs Major DealGap Up/Gap Down Analysis & Budget Friendly Trading Strategies - bollywoodhelpline.com
Biomerica Adds Most New Retail Followers Among Biotechs After UAE Nod For Prostate Cancer Screening Test - MSN
Biomerica (NASDAQ:BMRA) Stock Crosses Below Two Hundred Day Moving Average – Time to Sell? - Defense World
Biomerica (BMRA) Stock Analysis Report | Ratings, Financials & Performance - Benzinga España
Biomerica stock soars after Medicare sets $300 payment rate for IBS test - Investing.com Australia
Medicare to pay $300 for Biomerica’s IBS test starting January 2026 - Investing.com Nigeria
Biomerica Gains Exposure as Distribution Expands in Egypt - StocksToTrade
Biomerica’s Market Presence Expands with Egyptian Drug Authority Authorization - timothysykes.com
Biomerica stock soars after Medicare sets $300 payment rate for IBS test By Investing.com - Investing.com Nigeria
Medicare to pay $300 for Biomerica’s IBS test starting January 2026 By Investing.com - Investing.com South Africa
Biomerica, Inc. Announces Medicare Payment Rate for inFoods® IBS Test Set at $300 Effective January 1, 2026 - Quiver Quantitative
Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test - The Manila Times
Biomerica announces CMS Medicare payment rate of $300 for revolutionary Infoods® IBS test - marketscreener.com
Medicare sets $300 price for new food-trigger test to ease IBS pain - Stock Titan
Why Biomerica Inc. stock remains a top recommendationJuly 2025 Analyst Calls & Verified Technical Trade Signals - Улправда
Biomerica stockholders approve key proposals at annual meeting - MSN
Will Biomerica Inc. stock attract more institutional investorsTrade Signal Summary & Expert Verified Movement Alerts - Улправда
Market Review: Is Biomerica Inc. stock a safe haven assetMarket Activity Recap & Scalable Portfolio Growth Methods - Улправда
Will Biomerica Inc. stock recover faster than marketWeekly Market Report & Consistent Income Trade Ideas - Улправда
Can Biomerica Inc. stock maintain operating marginsTrade Volume Report & Stock Portfolio Risk Management - Улправда
What makes Biomerica Inc. stock attractive to growth fundsSmall Cap Stock Opportunities & Minimal Capital Investment - ulpravda.ru
Is Biomerica Inc. stock a safe haven assetJuly 2025 PostEarnings & AI Enhanced Market Trend Forecasts - Улправда
Biomerica Earnings Notes - Trefis
Biomerica (NASDAQ:BMRA) Stock Crosses Below 200-Day Moving Average – What’s Next? - Defense World
Biomerica Stockholders Approve Key Proposals at Annual Meeting - TipRanks
Egyptian drug authority approves Biomerica’s cancer screening portfolio By Investing.com - Investing.com Australia
Biomerica (BMRA) Gains Approval for Rapid Tests in Egypt - GuruFocus
Egyptian drug authority approves Biomerica’s cancer screening portfolio - Investing.com
2.36%
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):